Advertisement
U.S. markets closed

Instil Bio, Inc. (TIL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
11.98+0.06 (+0.50%)
At close: 04:00PM EST
11.82 -0.16 (-1.34%)
After hours: 08:00PM EST
Full screen
Loading interactive chart...
  • Zacks

    Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why

    Instil's (TIL) recent deal with a collaborator to carry out preclinical manufacturing feasibility studies on its ITIL-306 program is a positive.

  • GlobeNewswire

    Instil Bio Announces Strategic Update

    DALLAS, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil” or the “Company”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announced a strategic update. Instil has entered into an agreement with a collaborator that has a successful track record of manufacturing and dosing patients with cell therapies to conduct preclinical manufacturing feasibility studies

  • GlobeNewswire

    Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split

    DALLAS, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil” or the “Company”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announced that a 1-for-20 reverse stock split of its outstanding shares of common stock will be effective as of 5:00 p.m. Eastern Time on Thursday, December 7, 2023. The Company’s common stock will begin trading on a reverse stock spli